|
Cerebrovascular Disease
Citations 201-210 of 236 total displayed.
|
Past content
(since Feb 1998):
|
- Contempo Updates
Anticoagulation for Chronic Atrial Fibrillation
- Scott Stern; Diane Altkorn; Wendy Levinson
JAMA 2000; 283: 2901-2903.
[Extract]
[Full text]
[PDF]
- Original Contributions
Physical Activity and Risk of Stroke in Women
- Frank B. Hu; Meir J. Stampfer; Graham A. Colditz; Alberto Ascherio; Kathryn M. Rexrode; Walter C. Willett; JoAnn E. Manson
JAMA 2000; 283: 2961-2967.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Calcification of the Aortic Arch: Risk Factors and Association With Coronary Heart Disease, Stroke, and Peripheral Vascular Disease
- Carlos Iribarren; Stephen Sidney; Barbara Sternfeld; Warren S. Browner
JAMA 2000; 283: 2810-2815.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Intravenous Ancrod for Treatment of Acute Ischemic Stroke: The STAT Study: A Randomized Controlled Trial
- David G. Sherman; Richard P. Atkinson; Thomas Chippendale; Kenneth A. Levin; Ken Ng; Nancy Futrell; Chung Y. Hsu; David E. Levy; for the STAT Participants
JAMA 2000; 283: 2395-2403.
[Abstract]
[Full text]
[PDF]
- Editorials
Ancrod—Is Snake Venom an Antidote for Stroke?
- Marc R. Mayberg; Anthony Furlan
JAMA 2000; 283: 2440-2442.
[Extract]
[Full text]
[PDF]
- Original Contributions
Impaired Cerebral Vasoreactivity and Risk of Stroke in Patients With Asymptomatic Carotid Artery Stenosis
- Mauro Silvestrini; Fabrizio Vernieri; Patrizio Pasqualetti; Maria Matteis; Francesco Passarelli; Elio Troisi; Carlo Caltagirone
JAMA 2000; 283: 2122-2127.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial
- Anthony Furlan; Randall Higashida; Lawrence Wechsler; Michael Gent; Howard Rowley; Carlos Kase; Michael Pessin; Arvind Ahuja; Fred Callahan; Wayne M. Clark; Frank Silver; Frank Rivera; for the PROACT Investigators
JAMA 1999; 282: 2003-2011.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study: A Randomized Controlled Trial
- Wayne M. Clark; Stanley Wissman; Gregory W. Albers; Jack H. Jhamandas; Kenneth P. Madden; Scott Hamilton; for the ATLANTIS Study Investigators
JAMA 1999; 282: 2019-2026.
[Abstract]
[Full text]
[PDF]
- Editorials
Conquering Cardiovascular Disease: Progress and Promise
- Claude Lenfant
JAMA 1999; 282: 2068-2070.
[Extract]
[Full text]
[PDF]
- Original Contributions
Fruit and Vegetable Intake in Relation to Risk of Ischemic Stroke
- Kaumudi J. Joshipura; Alberto Ascherio; JoAnn E. Manson; Meir J. Stampfer; Eric B. Rimm; Frank E. Speizer; Charles H. Hennekens; Donna Spiegelman; Walter C. Willett
JAMA 1999; 282: 1233-1239.
[Abstract]
[Full text]
[PDF]
|
|
